Showing results (111-120 of 190) with videos related to
Sort By:
Pageof 19
Neurotoxicology and Teratology|March 17, 2004
Prenatal stress, moderate fetal alcohol, and dopamine system function in rhesus monkeysA D Roberts, C F Moore, O T DeJesus, et al.Clinical Breast Cancer|May 13, 2009
Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up resultsAdam M Brufsky, Linda D Bosserman, Richard R Caradonna, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesM Lambertini, M Ceppi, F Poggio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancerC Mathias, C M Cardeal Mendes, E Pondé de Sena, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2S Damodaran, C C O'Sullivan, A Elkhanany, et al.Cancer|March 15, 2022
A randomized controlled trial of the effect of supervised exercise on functional outcomes in older African American and non-Hispanic White breast cancer survivors: Are there racial differences in the effects of exercise on functional outcomes?Cynthia Owusu, Seunghee Margevicius, Nora L Nock, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623Halle C F Moore, Stephanie J Green, Julie R Gralow, et al.Cancer|February 4, 2021
IMPROVE, a community-based exercise intervention versus support group to improve functional and health outcomes among older African American and Non-Hispanic White breast cancer survivors from diverse socioeconomic backgrounds: Recruitment strategies and baseline characteristicsCynthia Owusu, Nora L Nock, Vanessa Feuntes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222Halle C F Moore, William E Barlow, George Somlo, et al.Breast Cancer Research and Treatment|January 12, 2013
Supplement use during an intergroup clinical trial for breast cancer (S0221)Gary R Zirpoli, Patrick M Brennan, Chi-Chen Hong, et al.Pageof 19